-
Categories
-
Pharmaceutical Intermediates
-
Active Pharmaceutical Ingredients
-
Food Additives
- Industrial Coatings
- Agrochemicals
- Dyes and Pigments
- Surfactant
- Flavors and Fragrances
- Chemical Reagents
- Catalyst and Auxiliary
- Natural Products
- Inorganic Chemistry
-
Organic Chemistry
-
Biochemical Engineering
- Analytical Chemistry
- Cosmetic Ingredient
-
Pharmaceutical Intermediates
Promotion
ECHEMI Mall
Wholesale
Weekly Price
Exhibition
News
-
Trade Service
Recently, according to foreign media reports such as THE VERGE, Google's parent company Alphabet has established a new drug research and development company called Isomorphic Labs in the UK
The company will use the research of Google's artificial intelligence laboratory DeepMind to further explore the application of artificial intelligence (AI) in drug discovery
Isomorphic Labs: Building an artificial intelligence drug discovery model
Isomorphic Labs: Building an artificial intelligence drug discovery modelHassabis stated on his personal blog that Isomorphic Labs will try to build models that can predict how drugs interact with the body
The work done at DeepMind and the work planned to be done at Isomorphic Labs can help new drugs find and solve some research bottlenecks, such as the problem of reasonable chemical level but not always effective when administered to animals or humans, but it cannot quickly solve the numerous problems of drug development.
Research progress of DeepMind under Google
Research progress of DeepMind under GoogleAlphabet also has several other companies dedicated to healthcare, including Verily, which develops software for the healthcare industry, and Calico, which is dedicated to aging and extending human life
Since then, DeepMind has begun to conduct research in other fields of life sciences and has made breakthroughs in the field of protein folding
Specifically, AlphaFold2 accurately predicts the 3D structure of a protein based on the amino acid sequence in the International Protein Structure Prediction Competition (CASP)
In July 2021, the DeepMind team under Google and the European Institute of Bioinformatics (EMBL-EBI) collaborated to release the AlphaFold Protein Structure Database predicted by the artificial intelligence system AlphaFold
Hassabis believes that artificial intelligence methods will be increasingly used not only to analyze data, but also to build powerful prediction and generative models of complex biological phenomena, helping scientists to take their work to a new level and greatly speed up drug discovery.
Note: The original text has been deleted
